A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Nathanne S. et al. NLRP3/inflammasome activation contributes to aldosterone-induced vascular dysfunction in type 2 diabetes. 2016, Anais.. Orlando: AHA, 2016. . Acesso em: 15 nov. 2024.
APA
Ferreira, N. S., Bruder-Nascimento, T., Pereira, C. A., Zanotto, C. Z., Prado, D. S., Alves-Filho, J. C., et al. (2016). NLRP3/inflammasome activation contributes to aldosterone-induced vascular dysfunction in type 2 diabetes. In Final Program. Orlando: AHA.
NLM
Ferreira NS, Bruder-Nascimento T, Pereira CA, Zanotto CZ, Prado DS, Alves-Filho JC, Carlos D, Tostes R de CA. NLRP3/inflammasome activation contributes to aldosterone-induced vascular dysfunction in type 2 diabetes. Final Program. 2016 ;[citado 2024 nov. 15 ]
Vancouver
Ferreira NS, Bruder-Nascimento T, Pereira CA, Zanotto CZ, Prado DS, Alves-Filho JC, Carlos D, Tostes R de CA. NLRP3/inflammasome activation contributes to aldosterone-induced vascular dysfunction in type 2 diabetes. Final Program. 2016 ;[citado 2024 nov. 15 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Camila A. et al. NLRP3 inflammasome activation by mitochondrial DNA contributes to oxidative stress and inflammation in the vasculature of type diabetic mice. 2016, Anais.. Orlando: AHA, 2016. . Acesso em: 15 nov. 2024.
APA
Pereira, C. A., Ferreira, N. S., Zanotto, C. Z., Carlos, D., & Tostes, R. de C. A. (2016). NLRP3 inflammasome activation by mitochondrial DNA contributes to oxidative stress and inflammation in the vasculature of type diabetic mice. In Final Program. Orlando: AHA.
NLM
Pereira CA, Ferreira NS, Zanotto CZ, Carlos D, Tostes R de CA. NLRP3 inflammasome activation by mitochondrial DNA contributes to oxidative stress and inflammation in the vasculature of type diabetic mice. Final Program. 2016 ;[citado 2024 nov. 15 ]
Vancouver
Pereira CA, Ferreira NS, Zanotto CZ, Carlos D, Tostes R de CA. NLRP3 inflammasome activation by mitochondrial DNA contributes to oxidative stress and inflammation in the vasculature of type diabetic mice. Final Program. 2016 ;[citado 2024 nov. 15 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEVES, Karla B. et al. Chemerin decreases vascular insulin signaling. 2014, Anais.. San Francisco: AHA, 2014. Disponível em: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf. Acesso em: 15 nov. 2024.
APA
Neves, K. B., Lobato, N. de S., Lopes, R. A., Mestriner, F. L. A. C., Oliveira, A. M. de, & Passaglia, R. de C. A. T. (2014). Chemerin decreases vascular insulin signaling. In Final Program. San Francisco: AHA. Recuperado de http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
NLM
Neves KB, Lobato N de S, Lopes RA, Mestriner FLAC, Oliveira AM de, Passaglia R de CAT. Chemerin decreases vascular insulin signaling [Internet]. Final Program. 2014 ;[citado 2024 nov. 15 ] Available from: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
Vancouver
Neves KB, Lobato N de S, Lopes RA, Mestriner FLAC, Oliveira AM de, Passaglia R de CAT. Chemerin decreases vascular insulin signaling [Internet]. Final Program. 2014 ;[citado 2024 nov. 15 ] Available from: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Rheure A. et al. Downregulation of vascular factor‐erythroid 2‐related factor‐2 and associated antioxidant enzymes in hypertension. 2014, Anais.. San Francisco: AHA, 2014. Disponível em: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf. Acesso em: 15 nov. 2024.
APA
Lopes, R. A., Neves, K. B., Montezano, A., Passaglia, R. de C. A. T., & Touyz, R. (2014). Downregulation of vascular factor‐erythroid 2‐related factor‐2 and associated antioxidant enzymes in hypertension. In Final Program. San Francisco: AHA. Recuperado de http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
NLM
Lopes RA, Neves KB, Montezano A, Passaglia R de CAT, Touyz R. Downregulation of vascular factor‐erythroid 2‐related factor‐2 and associated antioxidant enzymes in hypertension [Internet]. Final Program. 2014 ;[citado 2024 nov. 15 ] Available from: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
Vancouver
Lopes RA, Neves KB, Montezano A, Passaglia R de CAT, Touyz R. Downregulation of vascular factor‐erythroid 2‐related factor‐2 and associated antioxidant enzymes in hypertension [Internet]. Final Program. 2014 ;[citado 2024 nov. 15 ] Available from: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BROGNARA, Fernanda et al. The baroreflex modulates the anti-inflammatory response caused by intravenous lipopolysacharide (lps). 2014, Anais.. San Francisco: AHA, 2014. . Acesso em: 15 nov. 2024.
APA
Brognara, F., Becari, C., Castania, J. A., Dias, D. P. M., Tezini, G., Lopes, A., et al. (2014). The baroreflex modulates the anti-inflammatory response caused by intravenous lipopolysacharide (lps). In Final Program. San Francisco: AHA.
NLM
Brognara F, Becari C, Castania JA, Dias DPM, Tezini G, Lopes A, Cunha TM, Fazan Junior R, Salgado HC. The baroreflex modulates the anti-inflammatory response caused by intravenous lipopolysacharide (lps). Final Program. 2014 ;[citado 2024 nov. 15 ]
Vancouver
Brognara F, Becari C, Castania JA, Dias DPM, Tezini G, Lopes A, Cunha TM, Fazan Junior R, Salgado HC. The baroreflex modulates the anti-inflammatory response caused by intravenous lipopolysacharide (lps). Final Program. 2014 ;[citado 2024 nov. 15 ]
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEVES, Karla B. et al. Chemerin, a novel adipokine, regulates human vascular cell function through redox‐sensitive processes involving NADPH oxidase 1/4 and endothelial nitric oxide sinthase. 2014, Anais.. San Francisco: AHA, 2014. Disponível em: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf. Acesso em: 15 nov. 2024.
APA
Neves, K. B., Lopes, R. A., Nguyen, A. D., Lobato, N. S., Oliveira, A. M. de, Montezano, A. C., et al. (2014). Chemerin, a novel adipokine, regulates human vascular cell function through redox‐sensitive processes involving NADPH oxidase 1/4 and endothelial nitric oxide sinthase. In Final Program. San Francisco: AHA. Recuperado de http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
NLM
Neves KB, Lopes RA, Nguyen AD, Lobato NS, Oliveira AM de, Montezano AC, Passaglia R de CAT, Touyz RM. Chemerin, a novel adipokine, regulates human vascular cell function through redox‐sensitive processes involving NADPH oxidase 1/4 and endothelial nitric oxide sinthase [Internet]. Final Program. 2014 ;[citado 2024 nov. 15 ] Available from: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
Vancouver
Neves KB, Lopes RA, Nguyen AD, Lobato NS, Oliveira AM de, Montezano AC, Passaglia R de CAT, Touyz RM. Chemerin, a novel adipokine, regulates human vascular cell function through redox‐sensitive processes involving NADPH oxidase 1/4 and endothelial nitric oxide sinthase [Internet]. Final Program. 2014 ;[citado 2024 nov. 15 ] Available from: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVON, Vânia Cláudia et al. Acute increase in O‐GlcNAcylation reduces the release of cytokines and attenuates hypotension in mice with LPS‐induced sepsis. 2014, Anais.. San Francisco: AHA, 2014. Disponível em: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf. Acesso em: 15 nov. 2024.
APA
Olivon, V. C., Ferreira, R. G., Mestriner, F. L. A. C., Alves Filho, J. C. F., Cunha, F. de Q., & Passaglia, R. de C. A. T. (2014). Acute increase in O‐GlcNAcylation reduces the release of cytokines and attenuates hypotension in mice with LPS‐induced sepsis. In Final Program. San Francisco: AHA. Recuperado de http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
NLM
Olivon VC, Ferreira RG, Mestriner FLAC, Alves Filho JCF, Cunha F de Q, Passaglia R de CAT. Acute increase in O‐GlcNAcylation reduces the release of cytokines and attenuates hypotension in mice with LPS‐induced sepsis [Internet]. Final Program. 2014 ;[citado 2024 nov. 15 ] Available from: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
Vancouver
Olivon VC, Ferreira RG, Mestriner FLAC, Alves Filho JCF, Cunha F de Q, Passaglia R de CAT. Acute increase in O‐GlcNAcylation reduces the release of cytokines and attenuates hypotension in mice with LPS‐induced sepsis [Internet]. Final Program. 2014 ;[citado 2024 nov. 15 ] Available from: http://my.americanheart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_468057.pdf
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Fernanda Luciano et al. Toll-like receptor 9 (TLR9) plays a key role in the autonomic cardiac and baroreflex control of arterial pressure. 2013, Anais.. New Orleans: AHA, 2013. . Acesso em: 15 nov. 2024.
APA
Rodrigues, F. L., Bomfim, G. F., Silva, C. A. A. da, Fazan Júnior, R., Tostes, R. de C. A., & Carneiro, F. S. (2013). Toll-like receptor 9 (TLR9) plays a key role in the autonomic cardiac and baroreflex control of arterial pressure. In Abstracts. New Orleans: AHA.
NLM
Rodrigues FL, Bomfim GF, Silva CAA da, Fazan Júnior R, Tostes R de CA, Carneiro FS. Toll-like receptor 9 (TLR9) plays a key role in the autonomic cardiac and baroreflex control of arterial pressure. Abstracts. 2013 ;[citado 2024 nov. 15 ]
Vancouver
Rodrigues FL, Bomfim GF, Silva CAA da, Fazan Júnior R, Tostes R de CA, Carneiro FS. Toll-like receptor 9 (TLR9) plays a key role in the autonomic cardiac and baroreflex control of arterial pressure. Abstracts. 2013 ;[citado 2024 nov. 15 ]